Vista, CA, United States of America

Jason K Yano


Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 9(Granted Patents)


Location History:

  • Vista, CA (US) (2011)
  • Oceanside, CA (US) (2011)

Company Filing History:


Years Active: 2011

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Jason K Yano: Innovator in Cytochrome-Ligand Complex Research

Introduction

Jason K Yano is a notable inventor based in Vista, CA (US). He has made significant contributions to the field of biochemistry, particularly in the study of cytochrome-ligand complexes. With a total of 2 patents, Yano's work is paving the way for advancements in drug design and therapeutic applications.

Latest Patents

Yano's latest patents focus on the three-dimensional structure of a crystal of a cytochrome protein complexed with a ligand. His research discloses the three-dimensional structure of four cytochrome P450 2A6-ligand complexes. These structures, wherein the ligand acts as an inhibitor molecule, provide valuable structural information that can be integrated into drug screening and design processes. The methods outlined in his patents are aimed at identifying, designing, selecting, or testing inhibitors of the cytochrome protein. Such inhibitors hold promise as therapeutics for the treatment or modulation of various diseases and physiological events mediated by the cytochrome.

Career Highlights

Yano is affiliated with The Scripps Research Institute, where he continues to explore the complexities of cytochrome proteins. His work is instrumental in advancing our understanding of how these proteins interact with ligands, which is crucial for developing new therapeutic strategies.

Collaborations

Yano collaborates with Eric F Johnson, a fellow researcher, to further enhance the impact of their findings in the scientific community.

Conclusion

Jason K Yano's innovative research in cytochrome-ligand complexes is contributing significantly to the fields of biochemistry and drug design. His patents reflect a commitment to advancing therapeutic options for various diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…